Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MMP9 Genotype and Systemic T-Cell Subsets Correlate With Structural and Functional Outcomes in Neovascular Age-Related Macular Degeneration.

Investigative ophthalmology & visual science·2026
Same author

GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma.

Cancer research·2026
Same author

Cystoid Macular Edema in Retinitis Pigmentosa: Pathophysiologic Insight Using Swept-Source OCT and Angiography.

Ophthalmology science·2026
Same author

Vasculature: Choroid.

Handbook of clinical neurology·2026
Same author

Circulating natural killer cells are phenotypically and functionally altered in age-related macular degeneration.

Cell reports. Medicine·2026
Same author

Using Patient iPSC-derived Retinal Pigment Epithelial Cells to Evaluate Differential Susceptibility to MEK Inhibitor-Associated Retinopathy.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 13, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

Treating necrotizing fasciitis with or without hyperbaric oxygen therapy.

Zaheed Hassan1, Robert F Mullins, Bruce C Friedman

  • 1Joseph M Still Burn Centers, Inc., Augusta, Georgia, USA.

Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc
|May 14, 2010
PubMed
Summary

Adjuvant hyperbaric oxygen (HBO2) therapy for necrotizing fasciitis (NF) showed a trend towards reducing amputations. Further research is needed to confirm if HBO2 therapy can salvage extremities in NF patients.

Related Experiment Videos

Last Updated: Jun 13, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
07:22

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis

Published on: March 14, 2025

Area of Science:

  • Medical research
  • Surgical outcomes
  • Hyperbaric medicine

Background:

  • Necrotizing fasciitis (NF) is a severe infection requiring prompt surgical intervention.
  • The role of adjuvant hyperbaric oxygen (HBO2) therapy in NF management remains unclear due to limited clinical data.

Purpose of the Study:

  • To compare outcomes in NF patients treated with and without adjuvant HBO2 therapy.
  • To evaluate the potential of HBO2 therapy in reducing morbidity, specifically limb amputation.

Main Methods:

  • Retrospective review of 67 NF cases.
  • Comparison of outcomes between 29 patients receiving adjuvant HBO2 and 38 patients receiving standard care (surgery).
  • Analysis of length of hospital stay, mortality, and amputation rates.

Main Results:

  • No significant differences were found in average hospital stay or mortality between the groups.
  • A trend suggested HBO2 therapy may reduce amputation rates (1/29 vs. 6/38, Fisher exact p = 0.09).
  • The study did not achieve statistical significance but indicated potential benefits of HBO2 therapy.

Conclusions:

  • While not statistically significant, adjuvant HBO2 therapy shows a potential trend towards reducing amputations in NF patients.
  • Further multicenter, prospective studies are warranted to definitively assess the benefit of HBO2 therapy for NF.
  • Salvaging extremities may be a potential benefit of adjuvant HBO2 therapy in necrotizing fasciitis.